Infectious Dis. Medical News about Terbinafine

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Transplant + Vaccine Therapy Benefits High-Risk Leukemia Patients

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

HPV Prevalence at Root of Racial Disparity in Head and Neck Cancer

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Terbinafine: a pharmacological and clinical review
Expert Opinion in Pharmacotherapy, 11/03/09

Krishnan–Natesan S – Terbinafine has established itself as a drug of choice for dermatophytic infections; it must be considered in combination with other antifungal agents for the management of nondermatophytic refractory or resistant yeast/mold infections as well.

<< Previous
Propionibacterium acnes infection after shoulder arthroplasty: A...

Next >>
ABC - antibiotics-based combinations for the treatment of severe...